IMIQUIMOD
| Brand name | ZYCLARA |
|---|---|
| Active ingredient | IMIQUIMOD |
| Strength | 2.5% |
| Dosage form | CREAM |
| Route | TOPICAL |
| Modality | Small molecule |
| FDA approval | July 2011 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8222270 | December 2029 | use U-68 |
| 11318130 | December 2029 | use U-68 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.